SUZHOU HOWSINE BIOLOGICAL TECHNOLOGY CO.,LTD
SUZHOU HOWSINE BIOLOGICAL TECHNOLOGY CO.,LTD is a wholly owned subsidiary of Howsine Holdings Limited, a diversified investment-related international enterprise with its operational headquarters in Suzhou, China. The group’s development traces back to 2002, initially engaging in import and export trade of chemicals as part of its globalization efforts. Over time, Howsine expanded its focus to investment in the bio-chemical sector and implemented a brand strategy aimed at integrating export product resources. This involved corporate activities such as acquisitions, conglomeration, and mergers that have attracted factories to join the broader Howsine network.
Suzhou Howsine Biological Technology Co., Ltd was established in 2007 and positions itself as a leading research-based, customer-oriented high-tech company within the Howsine ecosystem. The company concentrates its product portfolio on amino acid series, fluor benzoic acid series, and fluor pyridine series, as well as APIs and pharmaceutical intermediates. Through its own independent and joint research and development institutions, along with stable production bases located in Jiangsu, Shandong, and other regions, Howsine aims to ensure steady new product development and production, maintaining a leading position in terms of quality, speed, and transformation capability.
Within the organizational framework, all Howsine brand products fall under the operational headquarters’ responsibilities for quotation, verification, and quality service management. This structure suggests a centralized approach to key commercial and quality assurance processes, supporting the company’s objective of providing reliable, research-driven biochemical products to its client base. The profile indicates a strong emphasis on research and development, integrated supply capabilities, and a focus on serving markets that require specialized chemical and pharmaceutical intermediate products. While the available information highlights the company’s strategic orientation and product categories, it remains a concise overview of its core activities and corporate lineage.
Overall, Suzhou Howsine Biological Technology Co., Ltd reflects a combination of scientific development and global trade operations typical of a modern biotech-oriented chemical producer. The company’s establishment within the Howsine framework underscores its role as a contributor to the broader portfolio of bio-chemical products and pharmaceutical intermediates, with a stated commitment to quality service and product development aligned with industry standards. The available data provides a snapshot of its domain, leadership, and the scale at which it operates within Jiangsu and neighboring regions, without delving into operational specifics beyond the scope of public-facing corporate information.
